CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
Four Years On: Children’s Mental Health Remains a National Emergency
6 Pediatric Medicine Breakthroughs Made Possible by Federal Research Funding
Why 340B Is Essential for Children's Health
Four Years On: Children’s Mental Health Remains a National Emergency
Children nationwide continue to struggle with anxiety, depression, suicidal thoughts, and other mental health conditions.
Oct. 20, 2025
6 Pediatric Medicine Breakthroughs Made Possible by Federal Research Funding
Life-changing scientific innovations from children’s hospitals show how public investment changes lives.
Oct. 14, 2025
Why 340B Is Essential for Children's Health
The program makes life-saving drugs more affordable for hospitals that care for our nation’s children.
Oct. 07, 2025
